Trualt Bioenergy IPO allotment: Here’s how to check status online as GMP remains healthy – News Air Insight

Spread the love


Trualt Bioenergy, one of India’s largest ethanol producers, closed its Rs 839 crore IPO on September 29. With a healthy subscription of 75.02 times, the issue drew strong interest from all investor categories. The allotment of shares is set to be finalised on September 30, and investors are now keen to know whether they got lucky.

The IPO, priced between Rs 472–496 per share, comprised a fresh issue of Rs 750 crore and an offer-for-sale worth Rs 89.28 crore. Ahead of the issue, Trualt raised Rs 252 crore from anchor investors. The stock is slated to debut on the BSE and NSE on October 3.

Market watchers note that Trualt is commanding a grey market premium (GMP) of 22%, hinting at a strong listing if current sentiments sustain.

How to check allotment status:

Investors can check their allotment in two simple ways:

1) On the Registrar’s Website (Bigshare Services)

Visit the registrar’s IPO allotment page. https://ipo.bigshareonline.com/ipo_status.jsp

Select Trualt Bioenergy IPO from the dropdown menu.

Enter your PAN, application number, or DP/Client ID.

Click Submit to view your allotment status.

2) Go to the BSE IPO allotment page https://www.bseindia.com/investors/appli_check.aspx

Select Equity under Issue Type and choose Trualt Bioenergy IPO.

Enter your application number and PAN.

The portal will display whether shares have been allotted and the number of shares credited to your demat account.

What’s next for investors?

Trualt Bioenergy plans to utilize IPO proceeds to expand its ethanol capacity, fund working capital, and support new verticals like compressed biogas and sustainable aviation fuel.

Financially, the company reported 54% revenue growth and a 361% surge in profits in FY25. Post issue, it will have a market cap of over Rs 4,250 crore.

While the GMP suggests healthy listing gains, analysts caution that valuations are already stretched at a post-issue P/E of around 29x. For investors allotted shares, the debut may bring near-term gains, but the bigger story lies in Trualt’s ability to deliver on growth plans in the competitive biofuels space.

Add ET Logo as a Reliable and Trusted News Source

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *